Advanced Materials Aerospace & defense Agriculture Automation & Process Control Automotive & Transportation Banking & Financial Services Biotechnology Building & Construction Chemicals Cloud Computing Communications Devices and Infrastructure Consumer Goods Country Reports Cyber Security Data Center & Networking Energy Energy Utilities Food & Beverage Global Reports Healthcare Industrial Goods Industry Updates Information and Communications Technology IoT, Bigdata & Digitalization IT & Telecom Medical Devices Mining, Minerals and Metals Networking and Communications Next-Generation Networking Technologies Oil & Gas Outsourcing Services Packaging Pharmaceuticals Regional Reports Semiconductor & Electronics Software & Solutions Technology & Media Travel & Tourism
-
Asia Pacific Gastrointestinal Drugs Market
The Asia Pacific Gastrointestinal Drugs Market size was valued at USD 14,076.07 MN in 2021 and reached USD 18,379.23 MN in 2025. It is anticipated to reach USD 27,675.57 MN by 2032, growing at a CAGR of 4.86% during the forecast period.
-
Asia Pacific Cancer Biopsy Market
The Asia Pacific Cancer Biopsy Market size was valued at USD 2,917.45 MN in 2021 and reached USD 4,124.28 MN in 2025. It is anticipated to reach USD 8,097.12 MN by 2032, growing at a CAGR of 8.52% during the forecast period.
-
North America Immunology Drugs Market
The North America Immunology Drugs Market size was valued at USD 23,174.02 MN in 2021 and reached USD 34,194.85 MN in 2025. It is anticipated to reach USD 70,564.69 MN by 2032, growing at a CAGR of 9.11% during the forecast period.
-
North America Anti-Infectives Market
The North America Anti-Infectives Market size was valued at USD 26,431.85 MN in 2021 and reached USD 31,551.94 MN in 2025. It is anticipated to reach USD 43,808.54 MN by 2032, growing at a CAGR of 4.03% during the forecast period.
-
Europe Anticancer Drugs/Oncology Drugs Market
The Europe Anticancer Drugs/Oncology Drugs Market size was valued at USD 52,704.85 MN in 2021 and reached USD 71,835.97 MN in 2025. It is anticipated to reach USD 125,841.34 MN by 2032, growing at a CAGR of 8.34% during the forecast period.
-
North America Checkpoint Inhibitor Refractory Cancer Market
The North America Checkpoint Inhibitor Refractory Cancer Market size was valued at USD 7,532.84 MN in 2021 and reached USD 15,533.16 MN in 2025. It is anticipated to reach USD 34,645.48 MN by 2032, growing at a CAGR of 12.06% during the forecast period.
-
North America Cardiovascular Devices Market
The North America Cardiovascular Drugs Market size was valued at USD 35,146.60 MN in 2021 and reached USD 46,140.28 MN in 2025. It is anticipated to reach USD 70,300.43 MN by 2032, growing at a CAGR of 5.01% during the forecast period.
-
North America Antidiabetics Drug Market
The North America Antidiabetics Drug Market size was valued at USD 18,811.60 MN in 2021 and reached USD 25,029.65 MN in 2025. It is anticipated to reach USD 42,563.34 MN by 2032, growing at a CAGR of 6.60% during the forecast period.
-
North America Emotion Detection & Recognition Market
The North America Emotion Detection & Recognition Market size was valued at USD 8,912.22 MN in 2021 and reached USD 13,270.48 MN in 2025. It is anticipated to reach USD 29,514.36 MN by 2032, growing at a CAGR of 10.23% during the forecast period.
-
North America Bioprocess Technology Market
The North America Bioprocess Technology Market size was valued at USD 13,243.48 MN in 2021 and reached USD 18,584.71 MN in 2025. It is anticipated to reach USD 36,676.90 MN by 2032, growing at a CAGR of 8.63% during the forecast period.
